Analysts’ View: Tetraphase Pharmaceuticals (TTPH), PG&E (PCG), TCF Financial (TCF)

Brokerage Firm WBB Securities upgraded Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) shares from Speculative Buy to Buy rating with a price target of $7.

Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops various antibiotics for the treatment of serious and life-threatening multidrug-resistant infections.

*

PG&E Corporation (NYSE:PCG) shares were upgraded by analysts at Argus from Hold to Buy rating.

PG&E Corporation, through its subsidiary, Pacific Gas and Electric Company, engages in the sale and delivery of electricity and natural gas to residential, commercial, industrial, and agricultural customers in northern and central California, the United States.

*

Investment Analysts at BofA/Merrill upgraded TCF Financial Corporation (NYSE:TCF) shares from Neutral to Buy rating.

TCF Financial Corporation operates as the holding company for TCF National Bank that provides various financial products and services in the United States and Canada.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/